Co-Diagnostics, Inc.

US$0.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CODXHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (48.77%)
Div yield —
ROE (174.77%)
Medical Devices
Beta (5Y) 3.20
PE TTM —
TSR TTM (98.14%)
Mkt cap US$2.041M
ROIC (290.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.298
15.87%
(91.66%)
Sell 5|3|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
(3.26%)
(2.30%)
(5.28%)
5.66%
Revenue$M
0.101
0.107
0.112
0.113
(2.60%)
1.63%
6.64%
9.95%
Peers (US$2.041M)
Cap (US$)
PE
2.126M
—
1.856M
—
Capital
TTM
5Y
10Y
Leveragex
0.844
(0.091)
(0.094)
EBIT/Intx
0.786
0.568
0.545
Own earn%
(56.90)
127.44
135.51
Sh yield%
28.83
40.53
38.51
Owners
Insiders/Inst%
13.74
40.91
Short interest%
5.60
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
2–10
$1 testx
—
Incr. ROIC%
18